$SHFH

Scientist Home Future Health Ltd

CIK:0002032609|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues:
Retail trading revenue	$ 82,878	$ 31,552	$ 265,156	$ 76,376
Service revenue	1,425	0	7,903	0
Cost of revenues:
Cost of revenues (including $55,194 and $18,013 of cost of revenues to related party for the three months ended June 30, 2026 and 2025 respectively; including $184,882 and $43,148 of cost of revenues to related party for the six months ended June 30, 2026 and 2025)	(55,194)	(18,013)	(184,882)	(43,148)
Cost of service revenue	0	0	0	0
Gross profit	29,109	13,539	88,177	33,228
Selling, general and administrative expenses (including $5,744 and $3,844 of selling, general and administrative expenses to related party for the three months ended June 30, 2026 and 2025 respectively; including $11,503 and $7,700 of selling, general and administrative expenses to related party for the six months ended June 30, 2026 and 2025)	(126,961)	(51,687)	(288,101)	(64,382)
Loss from operation	(97,852)	(38,148)	(199,924)	(31,154)
Other Income	0	0	0	0
Loss before income tax	(97,852)	(38,148)	(199,924)	(31,154)
Income tax benefit	0	935	0	0
Net loss	(97,852)	(37,213)	(199,924)	(31,154)
Other comprehensive income:
Foreign currency translation	101	219	209	207
Total comprehensive Loss	$ (97,751)	$ (36,994)	$ (199,715)	$ (30,947)
Net loss per share, basic and diluted	$ (0.00)	$ (0.00)	$ (0.01)	$ (0.00)
Weighted average number of common shares outstanding - basic and diluted	23,716,000	23,500,571	23,716,000	23,490,343

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (199,924)	$ (31,154)
Adjustments to reconcile net profit to net cash used in operating activities:
Depreciation	7,450	0
Amortization of operating lease right-of-use assets	36,867	0
Changes in operating assets and liabilities:
Inventories	(146)	(724)
Deposits and prepayments	6,325	0
Other payables and accrued liabilities	25,415	1,100
Amount due to a related party	75,765	20,652
Change in lease liability	(36,408)	0
Net cash used in operating activities	(84,656)	(10,126)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of shares	0	88,500
Amount due to a director	12,324	1,626
Amount due to a related party	12,781	12,833
Net cash provided by financing activities	25,105	102,959
Effect of exchange rate changes in cash and cash equivalents	(290)	(68)
Net (decrease)/increase in cash and cash equivalents	(59,841)	92,765
Cash and cash equivalents, beginning of period/at date of inception	68,888	18,621
CASH AND CASH EQUIVALENTS, END OF PERIOD	9,047	111,386
SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid	0	0
Interest paid	0	0
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVTIES
Initial recognition of operating lease right-of-use assets and operating lease obligations upon adoption of ASC Topic 842	400,739	0
Initial recognition of the balance payment of finance lease right-of-use asset by finance lease liabilities	$ 0	$ 0

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 9,047	$ 68,888
Inventories	33,898	34,006
Deposits and prepayments	82,379	89,352
Total current assets	125,324	192,246
Non-current assets
Right-of-use assets, net (including $22,411 and $33,435 of right-of-use assets from related party as of June 30, 2026 and December 31, 2025, respectively)	339,326	378,944
Property, plant and equipment, net	65,194	73,175
Total non-current assets	404,520	452,119
Total assets	529,844	644,365
Current liabilities
Other payables and accrued liabilities	69,762	44,635
Income tax payable	1,817	1,831
Amount due to a related party	165,364	78,260
Amount due to a director	27,790	15,565
Lease liability - current portion (including $22,411 and $21,997 of lease liability - current portion to related party as of June 30, 2026 and December 31, 2025, respectively)	75,566	74,167
Total current liabilities	340,299	214,458
Non-current liabilities
Lease liability - non-current portion (including $nil and $11,438 lease liability - non-current portion to related party as of June 30, 2026 and December 31, 2025, respectively)	275,869	316,516
Total non-current liabilities	275,869	316,516
Total liabilities	616,168	530,974
Stockholders' equity
Common stock, par value $0.0001; 200,000,000 shares authorized, 23,716,000 and 23,716,000 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	2,372	2,372
Additional paid in capital	360,588	360,588
Accumulated other comprehensive income	(2,655)	(2,864)
Accumulated deficit	(446,629)	(246,705)
Total stockholders' equity	(86,324)	113,391
Total liabilities and stockholders' equity	$ 529,844	$ 644,365